Skip to main content

Research Repository

Advanced Search

EU Clinical Trials Regulation 2014: Fetter or facilitator?

Cave, Emma

EU Clinical Trials Regulation 2014: Fetter or facilitator? Thumbnail


Authors



Abstract

European Union (EU) Clinical Trials Regulation 536/2014, expected to come into force in 2019, provides for a streamlined single EU application for cross-border clinical trials and enhanced transparency of results. The status of the Regulation in post-Brexit UK is uncertain. Matters of regulatory alignment will be covered by agreements on the future EU-UK relationship. In the short term, implementation of the Regulation in the United Kingdom depends on the Brexit model and timing of the Regulation’s implementation. The EU (Withdrawal) Act will convert EU law into UK law, including the vast array of EU life sciences regulation. However, the Regulation is likely to be implemented after the United Kingdom leaves the EU, but within the transition period. If the United Kingdom is not part of the legal framework governing clinical trials in the EU, then the United Kingdom will still need to comply with the global framework set out in the International Council on Harmonisation if it wants to be part of trials of medicinal products for which marketing authorization will be sought for licensing in the European Economic Area. This article extols the virtues of harmonization with the EU and attempts to counter some of the media focus on the advantages of a deregulated bespoke approach.

Citation

Cave, E. (2018). EU Clinical Trials Regulation 2014: Fetter or facilitator?. Medical Law International, 18(2-3), 179-194. https://doi.org/10.1177/0968533218799535

Journal Article Type Article
Acceptance Date May 23, 2018
Online Publication Date Sep 9, 2018
Publication Date Sep 9, 2018
Deposit Date Sep 12, 2018
Publicly Available Date Sep 13, 2018
Journal Medical Law International
Print ISSN 0968-5332
Electronic ISSN 2047-9441
Publisher SAGE Publications
Peer Reviewed Peer Reviewed
Volume 18
Issue 2-3
Pages 179-194
DOI https://doi.org/10.1177/0968533218799535
Keywords Clinical trials, Brexit.

Files


Published Journal Article (Advance online version) (257 Kb)
PDF

Publisher Licence URL
http://creativecommons.org/licenses/by-nc/4.0/

Copyright Statement
Advance online version This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).







You might also like



Downloadable Citations